Last 24 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q4 '25 | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 | Q4 '20 | Q2 '20 | Q4 '19 | Q2 '19 | Q4 '18 | Q2 '18 | Q4 '17 | Q2 '17 | Q4 '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 21.63 | 10.73 | 10.79 | 11.26 | 13.36 | 12.39 | 32.48 | 20.67 | 61.11 | 17.45 | 12.02 | 22.63 | 13.18 | 41.43 | 17.67 | 15.12 | 10.62 | 14.66 | 8.75 | 11.46 | 6.06 |
| — | -13.4% | -66.8% | -45.5% | -78.1% | -29.0% | +170.2% | -8.6% | +363.8% | -57.9% | -32.0% | +49.7% | +24.1% | +182.6% | +101.9% | +31.9% | +75.1% | -11.2% | -74.4% | -13.6% | -70.9% | |
| P/S Ratio | 2.12 | 1.04 | 1.12 | 1.14 | 0.91 | 0.96 | 2.11 | 2.57 | 2.24 | 2.35 | 2.91 | 3.68 | 3.68 | 4.11 | 3.97 | 3.85 | 3.31 | 3.38 | 3.15 | 3.27 | 2.86 |
| — | +9.1% | -47.1% | -55.8% | -59.5% | -59.3% | -27.3% | -30.0% | -39.2% | -42.7% | -26.7% | -4.4% | +10.9% | +21.6% | +26.0% | +17.7% | +15.9% | +2.3% | -7.0% | -2.8% | -20.8% | |
| P/B Ratio | 2.57 | 2.50 | 2.71 | 2.44 | 2.05 | 2.08 | 4.56 | 5.38 | 4.45 | 4.53 | 5.46 | 7.17 | 7.03 | 6.74 | 8.19 | 7.72 | 6.70 | 7.10 | 6.59 | 7.26 | 6.76 |
| — | +20.0% | -40.7% | -54.7% | -53.8% | -54.1% | -16.4% | -24.9% | -36.8% | -32.7% | -33.4% | -7.1% | +5.0% | -5.0% | +24.3% | +6.3% | -0.9% | -8.9% | -18.3% | -3.7% | -17.6% | |
| P/FCF | 15.35 | 12.43 | 6.02 | 13.11 | 5.01 | 40.99 | 25.33 | — | 76.93 | 179.89 | 27.04 | 50.82 | 15.29 | — | 22.79 | 32.06 | 17.56 | 69.24 | 12.57 | 44.10 | 15.42 |
| — | -69.7% | -76.2% | — | -93.5% | -77.2% | -6.3% | — | +403.1% | — | +18.6% | +58.5% | -12.9% | — | +81.4% | -27.3% | +13.9% | +71.1% | -37.5% | +90.1% | -71.4% | |
| EV / EBITDA | 11.60 | 5.33 | 6.44 | 5.79 | 4.82 | 5.79 | 12.39 | 13.82 | 12.56 | 12.18 | 12.94 | 18.95 | 15.82 | 33.58 | 15.30 | 15.09 | 11.11 | 14.32 | 12.28 | 12.68 | 10.41 |
| — | -7.8% | -48.1% | -58.1% | -61.6% | -52.5% | -4.3% | -27.1% | -20.6% | -63.7% | -15.4% | +25.6% | +42.5% | +134.5% | +24.6% | +19.0% | +6.7% | +8.1% | -4.2% | +10.4% | -33.9% | |
| EV / EBIT | 19.96 | 8.91 | 9.54 | 9.47 | 6.05 | 10.60 | 14.27 | 28.19 | 15.76 | 27.73 | 17.15 | 42.26 | 22.29 | — | 19.52 | 24.02 | 13.97 | 23.10 | 16.93 | 19.39 | 13.78 |
| — | -16.0% | -33.2% | -66.4% | -61.6% | -61.8% | -16.8% | -33.3% | -29.3% | — | -12.2% | +75.9% | +59.5% | — | +15.3% | +23.9% | +1.4% | +13.3% | -5.6% | +14.0% | -48.7% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q4 '25 | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 | Q4 '20 | Q2 '20 | Q4 '19 | Q2 '19 | Q4 '18 | Q2 '18 | Q4 '17 | Q2 '17 | Q4 '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 68.3% | 70.9% | 66.1% | 70.6% | 70.6% | 69.8% | 70.9% | 69.4% | 71.4% | 70.3% | 72.9% | 69.0% | 70.9% | 68.3% | 74.3% | 73.9% | 73.8% | 73.2% | 73.4% | 74.2% | 72.7% |
| — | +1.5% | -6.9% | +1.7% | -1.2% | -0.6% | -2.7% | +0.6% | +0.8% | +3.0% | -1.8% | -6.7% | -4.0% | -6.8% | +1.1% | -0.4% | +1.6% | +0.5% | -2.8% | -1.2% | -2.0% | |
| Operating Margin | 12.9% | 14.5% | 11.4% | 14.5% | 11.0% | 11.6% | 5.3% | 10.1% | 8.0% | 9.3% | 13.5% | 9.2% | 17.3% | -0.2% | 21.2% | 16.9% | 24.5% | 15.2% | 19.4% | 17.7% | 22.0% |
| — | +24.7% | +113.9% | +44.0% | +38.7% | +24.7% | -60.7% | +9.4% | -54.1% | +3888.2% | -36.0% | -45.5% | -29.2% | -101.6% | +9.2% | -4.9% | +11.6% | -10.8% | -1.5% | -14.5% | +57.5% | |
| Net Margin | 10.1% | 9.8% | 10.4% | 9.9% | 6.6% | 7.6% | 3.2% | 6.3% | 1.8% | 6.8% | 12.2% | 7.9% | 13.8% | 4.9% | 11.0% | 12.4% | 15.8% | 11.2% | 18.2% | 13.9% | 23.2% |
| — | +29.2% | +220.6% | +57.3% | +277.3% | +11.2% | -73.5% | -20.2% | -87.2% | +38.5% | +11.3% | -36.6% | -12.7% | -56.2% | -39.9% | -10.3% | -31.9% | +8.5% | +274.6% | +6.8% | +161.1% |
| Metric | TTM | Q2 '26 | Q4 '25 | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 | Q4 '20 | Q2 '20 | Q4 '19 | Q2 '19 | Q4 '18 | Q2 '18 | Q4 '17 | Q2 '17 | Q4 '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 11.8% | 5.8% | 6.1% | 5.4% | 3.8% | 4.1% | 1.7% | 3.3% | 0.9% | 3.2% | 5.9% | 3.9% | 6.8% | 2.0% | 5.8% | 6.3% | 8.2% | 5.9% | 10.0% | 7.9% | 13.7% |
| — | +41.0% | +252.4% | +65.6% | +338.0% | +27.2% | -70.2% | -15.2% | -87.3% | +63.1% | +1.5% | -38.6% | -16.8% | -66.4% | -42.4% | -20.8% | -40.5% | -3.2% | +249.1% | +8.9% | +176.0% | |
| ROA | 6.0% | 2.8% | 3.1% | 2.8% | 1.9% | 2.1% | 0.9% | 1.7% | 0.5% | 1.7% | 2.9% | 1.9% | 3.4% | 1.1% | 3.2% | 3.6% | 4.9% | 3.5% | 5.8% | 4.4% | 7.3% |
| — | +35.4% | +242.2% | +60.4% | +313.4% | +23.8% | -68.6% | -7.1% | -86.5% | +58.6% | -8.5% | -48.6% | -31.3% | -69.8% | -44.9% | -17.1% | -32.6% | +7.1% | +262.0% | +7.9% | +169.8% | |
| ROIC | 7.4% | 4.1% | 3.3% | 4.0% | 3.0% | 3.0% | 1.4% | 2.6% | 2.0% | 2.4% | 3.5% | 2.4% | 4.5% | -0.1% | 6.1% | 4.8% | 7.5% | 4.7% | 6.0% | 5.5% | 6.9% |
| — | +36.8% | +139.1% | +52.1% | +51.3% | +28.0% | -60.1% | +6.7% | -55.9% | +4550.6% | -42.1% | -49.7% | -39.7% | -101.1% | +0.6% | -11.7% | +8.9% | -14.4% | -6.0% | -12.9% | +68.9% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q4 '25 | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 | Q4 '20 | Q2 '20 | Q4 '19 | Q2 '19 | Q4 '18 | Q2 '18 | Q4 '17 | Q2 '17 | Q4 '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.63 | 0.73 | 0.63 | 0.62 | 0.63 | 0.70 | 0.59 | 0.58 | 0.55 | 0.54 | 0.60 | 0.67 | 0.70 | 0.53 | 0.40 | 0.44 | 0.30 | 0.32 | 0.31 | 0.40 | 0.42 |
| — | +4.1% | +6.4% | +7.4% | +15.5% | +31.0% | -1.4% | -13.2% | -21.9% | +0.8% | +50.6% | +52.0% | +132.6% | +64.0% | +27.5% | +10.8% | -27.9% | -28.1% | -16.3% | +0.6% | -1.2% | |
| Debt / EBITDA | 2.43 | 5.06 | 5.01 | 4.92 | 4.74 | 6.08 | 5.75 | 5.42 | 5.57 | 5.25 | 5.33 | 6.69 | 5.98 | 9.92 | 2.85 | 3.27 | 1.93 | 2.51 | 2.23 | 2.64 | 2.43 |
| — | -16.8% | -12.8% | -9.3% | -14.9% | +15.8% | +7.9% | -19.0% | -6.9% | -47.1% | +86.7% | +104.8% | +210.3% | +295.3% | +27.8% | +24.0% | -20.6% | -13.7% | -1.9% | +14.9% | -21.4% | |
| Current Ratio | 2.57 | 2.14 | 2.57 | 3.00 | 2.89 | 2.51 | 1.77 | 2.19 | 2.25 | 1.78 | 2.08 | 2.10 | 2.76 | 2.18 | 2.06 | 2.00 | 2.10 | 2.13 | 2.03 | 2.18 | 1.88 |
| — | -14.7% | +45.0% | +36.8% | +28.4% | +41.3% | -14.5% | +4.7% | -18.6% | -18.4% | +0.9% | +4.7% | +31.6% | +2.2% | +1.4% | -8.1% | +12.0% | +12.3% | +10.2% | +9.6% | -10.7% | |
| Quick Ratio | 1.25 | 1.11 | 1.25 | 1.40 | 1.33 | 1.11 | 0.72 | 0.83 | 0.96 | 0.84 | 1.21 | 1.27 | 1.76 | 1.04 | 1.03 | 0.96 | 1.15 | 1.05 | 1.06 | 1.08 | 0.95 |
| — | +0.2% | +72.9% | +68.8% | +38.0% | +32.5% | -40.5% | -34.6% | -45.3% | -19.7% | +18.0% | +32.1% | +53.4% | -0.5% | -3.2% | -11.1% | +20.4% | +11.5% | +13.3% | +6.2% | -12.0% | |
| Interest Coverage | 6.21 | 8.15 | 6.00 | 5.25 | 6.13 | 4.00 | 6.04 | 4.41 | 8.57 | 6.03 | 10.30 | 4.70 | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 24 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SNN stock.
Smith & Nephew plc's current P/E is 21.6x. The average P/E over the last 4 quarters is 11.5x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Smith & Nephew plc's current operating margin is 12.9%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Smith & Nephew plc's business trajectory between earnings reports.